<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Светлана Мусина on Leukoformula</title><link>https://www.leukoformula.com/en/authors/svetlana-musina/</link><description>Recent content in Светлана Мусина on Leukoformula</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Mon, 06 Apr 2020 09:52:00 +0300</lastBuildDate><atom:link href="https://www.leukoformula.com/en/authors/svetlana-musina/feed.xml" rel="self" type="application/rss+xml"/><item><title>Howell-Jolly Bodies &amp; Cabot Rings: Morphology in Blood Smear</title><link>https://www.leukoformula.com/en/post/telca-zholli-i-kolca-kebota-morfologiya-v-mazke-2670/</link><pubDate>Mon, 06 Apr 2020 09:52:00 +0300</pubDate><guid>https://www.leukoformula.com/en/post/telca-zholli-i-kolca-kebota-morfologiya-v-mazke-2670/</guid><description>&lt;p>Howell-Jolly bodies are remnants of nuclear material (small, dark purple inclusions) observed in megaloblastic anemias, hemolysis, and post-splenectomy states.
Cabot rings are remnants of the nuclear membrane (pale pink rings, ellipses, or figure-eights in erythrocytes).&lt;/p></description></item><item><title>AML with t(8;21) Differential Diagnosis: Cytology and Immunophenotyping</title><link>https://www.leukoformula.com/en/post/differencialnaya-diagnostika-oml-s-t-8-21-1403/</link><pubDate>Tue, 17 Sep 2019 12:54:15 +0300</pubDate><guid>https://www.leukoformula.com/en/post/differencialnaya-diagnostika-oml-s-t-8-21-1403/</guid><description>&lt;p>&amp;ldquo;Differential Diagnosis of AML with Translocation (8;21) from Acute Promyelocytic Leukemia&amp;rdquo; (Part 2)
Valentina Nikolaevna Dvirnyk, MD, PhD, Head of the Central Clinical Diagnostic Laboratory, National Medical Research Center for Hematology, Ministry of Health of the Russian Federation
V Russian Congress of Laboratory Medicine.&lt;/p></description></item><item><title>AML with t(8;21) Translocation: Morphology and Genetics</title><link>https://www.leukoformula.com/en/post/diagnostika-oml-s-translokaciey-t-8-21-1402/</link><pubDate>Tue, 17 Sep 2019 12:52:23 +0300</pubDate><guid>https://www.leukoformula.com/en/post/diagnostika-oml-s-translokaciey-t-8-21-1402/</guid><description>&lt;p>&amp;ldquo;Differential Diagnosis of AML with Translocation (8;21) from Acute Promyelocytic Leukemia&amp;rdquo; (Part 1)
Valentina Dvirnyk, MD, PhD, Head of the Central Clinical Diagnostic Laboratory, National Research Center for Hematology, Ministry of Health of the Russian Federation
V Russian Congress of Laboratory Medicine.&lt;/p></description></item><item><title>Sézary Cells in Blood Smear: A Guide to Identification</title><link>https://www.leukoformula.com/en/post/kletki-sezari-v-mazke-krovi-pri-sindrome-sezari-797/</link><pubDate>Sun, 07 Jul 2019 13:14:22 +0300</pubDate><guid>https://www.leukoformula.com/en/post/kletki-sezari-v-mazke-krovi-pri-sindrome-sezari-797/</guid><description>&lt;p>Sézary syndrome is a cutaneous T-cell lymphoma characterized by lymphadenopathy, erythroderma, and the presence of neoplastic T-lymphocytes with &amp;ldquo;cerebriform&amp;rdquo; nuclei (Sézary cells) in the peripheral blood and bone marrow. The nuclei occupy most of the cell, are heterogeneous, with a convoluted chromatin structure, and usually lack nucleoli.&lt;/p></description></item></channel></rss>